Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma
Open Liver Resection With or Without Vascular Inflow Occlusion for Hepatocellular Carcinoma: a Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
Bleeding is a major problem during liver resection. Vascular inflow occlusion, also known as Pringle maneuver, has been commonly employed to reduce blood loss during liver surgery. However, Pringle maneuver might cause ischaemic insult to the remnant liver and lead to post-operative liver dysfunction. The investigators hypothesize that liver resection without the use of vascular inflow occlusion (Pringle maneuver) is associated with lower postoperative complications rate. The aim of this study is to evaluate whether elective open liver resection without vascular inflow occlusion (Pringle Maneuvre) would lead to a reduction of post-operative surgical complications in patient with hepatocellular carcinoma. Eligible patients undergoing liver resection in the Prince of Wales Hospital will be recruited and randomized into 2 study arms comparing the effect of Pringle maneuver.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hepatocellular-carcinoma
Started Jan 2013
Typical duration for not_applicable hepatocellular-carcinoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 1, 2013
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedFirst Posted
Study publicly available on registry
January 3, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMarch 18, 2022
March 1, 2022
3.8 years
January 1, 2013
March 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative surgical complications
30-day morbidity after open liver resection, which includes ascites, pleural effusion, wound infection and intra-abdominal collection
1 month
Secondary Outcomes (3)
Other post-operative complications
1 month
Survival
5 year
Recurrence rate of hepatocellular carcinoma
5 year
Study Arms (2)
Pringle
EXPERIMENTALIntermittent vascular inflow occlusion applied during liver resection
Non-Pringle
NO INTERVENTIONNo vascular inflow occlusion applied during liver resection
Interventions
Vascular clamp is applied across hepatoduodenal ligament intermittently in 15 minutes on / 5 minutes off interval
Eligibility Criteria
You may qualify if:
- Age \>18
- Child's A or B cirrhosis
You may not qualify if:
- Informed consent not available
- Presence of portal vein thrombosis, portal vein tumor thrombus, or previous portal vein embolisation
- Presence of hepatic artery thrombosis, previous transarterial therapy like TACE, lipiodol-ethanol mixture injection or transarterial internal radiation
- Anticipation of portal vein resection
- Emergency hepatectomy
- Ruptured HCC
- Adhesion or anatomical variation that preclude safe and successful application of Pringle maneuver
- Anticipation of concomitant bowel or bile duct resection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Prince of Wales Hospital
Hong Kong, China
Related Publications (2)
Lee KF, Chong CCN, Cheung SYS, Wong J, Fung AKY, Lok HT, Lai PBS. Impact of Intermittent Pringle Maneuver on Long-Term Survival After Hepatectomy for Hepatocellular Carcinoma: Result from Two Combined Randomized Controlled Trials. World J Surg. 2019 Dec;43(12):3101-3109. doi: 10.1007/s00268-019-05130-8.
PMID: 31420724DERIVEDLee KF, Wong J, Cheung SYS, Chong CCN, Hui JWY, Leung VYF, Yu SCH, Lai PBS. Does Intermittent Pringle Maneuver Increase Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma? A Randomized Controlled Trial. World J Surg. 2018 Oct;42(10):3302-3311. doi: 10.1007/s00268-018-4637-3.
PMID: 29696328DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kit Fai Lee, MBBS
Clinical Associate Professor (honorary)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor (honorary)
Study Record Dates
First Submitted
January 1, 2013
First Posted
January 3, 2013
Study Start
January 1, 2013
Primary Completion
October 1, 2016
Study Completion
December 1, 2016
Last Updated
March 18, 2022
Record last verified: 2022-03